ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2467.4 | 2056.4 | 2041.9 |
| Other income | 5.9 | 11.5 | 8.0 |
| Total income | 2473.3 | 2067.9 | 2049.8 |
| Profit before exceptional items & tax | 127.2 | -103.1 | 222.1 |
| Profit before tax | 127.2 | -103.1 | 222.1 |
| Net profit | 95.7 | -76.5 | 150.7 |
| Operating margin | 5.1% | -5.0% | 10.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -36.50% |
|---|---|
| Revenue, year on year | +20.80% |
NSE results filing, NSE: RELIGARE. Figures extracted from the filing.
Religare Enterprises Ltd: key numbers
- Share price
- ₹233.93
- Market cap
- ₹8,065 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- -238.1×Sector 21.0×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Religare Enterprises Earnings Call Transcript: Key Takeaways
Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.
Religare Enterprises Investor Presentation: Key Takeaways
Religare H1 FY27 consolidated total income Rs4,717 Cr (+19% YoY); PAT loss Rs145 Cr vs Rs54 Cr profit last year. Care GWP growth drives insurance; Finvest lending restarted 6 Nov 2026.
Religare Enterprises Q2 FY27 Results: Net Loss of ₹97.7 Cr
Religare Enterprises Ltd reported revenue from operations of ₹2,381 Cr (+14.6% YoY) and a net loss of ₹97.7 Cr for Q2 FY27.
- Key figure
- Net loss ₹97.7 Cr
Religare Enterprises Employee Stock Options
Religare Enterprises' NRC granted 25,998 stock options under its ESOP 2019 scheme. Options vest in 5 equal annual tranches at Rs. 230.78 per share exercise price.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.